| Pharmaceutical active ingredients: |
| Tositumomab |
| Available forms, composition and doses of Bexxar Therapy: |
| Injectable; Injection; Tositumomab 14 mg / ml |
| Bexxar Therapy medical category: |
| Human:Antineoplastic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V10XA53 - Tositumomab / Iodine I-131 Tositumomab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Related documents and information about Bexxar Therapy: |
| Bexxar prescribing information (PDF) |